Comparison between triple therapy with octreotide, galanin and serotonin vs. irinotecan or oxaliplatin in combination with 5-fluorouracil/leukovorin in human colon cancer

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 687-691

  El Salhy, M ^a   Hilding, L ^a   Royson, H ^a   Tjomsland, V ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenocarcinoma; Colon; Galanin; Octreotide; Serotonin; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CD31 ANTIGEN; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR; FLUOROURACIL; FOLINIC ACID; GALANIN; IRINOTECAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OCTREOTIDE; OXALIPLATIN; PLATINUM COMPLEX; SEROTONIN; VASCULOTROPIN A;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; CELL PROLIFERATION; COLON TUMOR; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; NUDE MOUSE; PATHOLOGY; TIME; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, CD31; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BODY WEIGHT; CAMPTOTHECIN; CELL PROLIFERATION; COLONIC NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; FLUOROURACIL; GALANIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LEUCOVORIN; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OCTREOTIDE; ORGANOPLATINUM COMPOUNDS; POLY(ADP-RIBOSE) POLYMERASES; SEROTONIN; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 24344460350     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Primrose JN: Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 50: 1-5, 2002.
2. El-Salhy M: Triple treatment with octreotide, galanin and serotonin is a promising therapy for colorectal cancer. Curr Pharm Des (In press).
3. Faivre J, Bouvier A and Bonithon-Kopp C: Epidemiology and screening of colorectal cancer. Best Pract Res Clin Gastroenterol 16: 187-199,2002.
4. O'Connel MJ: Current status of adjuvant therapy for colorectal cancer. Oncology 18: 751-755, 2004.
5. Van Laarhoven H and Punt C: Systemic treatment of advanced colorectal carcinoma. Eur I Gastroenterol Hepatol 16: 283-289, 2004.
6. Taylor I, Goldberg MS and Garcia-Aguilar J: Advanced and recurrent disease. In: Fast Facts; Colorectal Cancer. Fine Print, Oxford, p53, 1999.
7. Penland SK and Goldberg RM: Current strategies in previously untreated colorectal cancer. Oncology 18: 715-722, 2004.
8. Goldberg RM: Current approaches to first-line treatment of advanced colorectal cancer. Clin Colorectal Cancer 1: 9-15, 2004.
9. Folprech G and Kohne CH: The role of new agents in the treatment of colorectal cancer. Oncology 66: 1-7, 2004.
10. Van Cutsem E, Verslype C and Demedts I: The treatment of advanced colorectal cancer: where are we now and where do we go? Best Pract Res Clin Gastroenterol 16: 319-330, 2002.
11. El-Salhy M, Sitohy B and Norrgård Ö: Triple therapy with octreotide, galanin and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma. RegulPept 111: 145-152,2002.
12. El-Sahly M and Sitohy B: Tripple therapy with octreotide, galanin and serotonin induces necrosis and increases apoptosis of a rat colon carcinoma. Regul Pept 108: 55-62, 2002.
13. Sitohy B and El-Salhy M: A comparison between double and triple therapies of octreotide, galanin and serotonin on a rat colon carcinoma. Histol Histopathol 18: 103-110,2003.
14. El-Salhy M: Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line. Oncol Rep 13: 45-49, 2005.
15. El-Salhy M: Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer: comparison between different routes of administration. Histol Histopathol 20: 19-25, 2005.
16. El-Salhy M and Starfeldt A: Direct effects of octreotide, galanin and serotonin on human colon cancer cells. Oncol Rep 10: 1723-1728,2003.
17. El-Salhy M and Dennerqvist V: Effects of triple therapy with octreotide, galanin and serotonin on liver metastasis of human colon cancer in xenografts. Oncol Rep 11: 1177-1182, 2004.
18. El-Salhy M: Comparison between triple therapy with octreotide, galanin and serotonin, 5-fluorouracil/Leukovorin, and sequential treatment with both, on human colon cancer. Oncol Rep 11: 1611-1618,2004.
19. El-Salhy M, Stalling R and Grimelius L: Peptidergic innervation and endocrine cells in the human liver. Scand I Gastroenterol 28:809-815, 1993.
20. Kerr J, Wexler R, Mousa S, Robinson C, Wexler E, Mohamed S, Voss M, Devenny J, Czermiak A Jr and Slee A: Novel small molecule of alpha v integrin antagonists: comparative anticancer efficacy with known angiogenesis inhibitors. Anticancer Res 19:959-968, 1999.
21. El-Salhy M, Sandström O, Näström E, Mustajbasic M and Zachrisson S: Application of computer image analysis. Histochem I 29: 249-255, 1997.